ARCHIVES

Four Patients In Tamoxifin Treatment Trial Had Died of Uterine Cancer Prior To BCPT

This article is from The Cancer Letter archive.

Vol. 20 No. 17 | April 29, 1994

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005

Rituximab After CVP Improves Progression-Free Survival

March 27, 2009

Foundations: Biomedical Foundation Formed to Support NIH

September 27, 1996

NHIS Cancer Control Supplement To Survey 52,000

October 4, 1985

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

FDA Selects 23 Survivors To Review Drug Applications.

June 15, 2001